The unprecedented demand placed on healthcare systems from the COVID-19 pandemic has forced a reassessment of clinical trial conduct and feasibility. Consequently, the AKTN had to efficiently respond and adapt to the changing landscape during COVID-19. Key priorities included ensuring patient and staff safety, trial integrity and network sustainability for the kidney care community. New resources have been developed to enable a structured review and contingency plan of trial activities during the pandemic and beyond.
Read more about how the AKTN responded to the COVID-19 pandemic here
Robison, L., Cho, Y., Viecelli, A.K. et al. Conducting clinical trials during the COVID-19 pandemic—a collaborative trial network response. Trials 22, 278 (2021). https://doi.org/10.1186/s13063-021-05200-0